doi: 10.3389/fimmu.2018.00268 Received 21 November 2017 Accepted 30 January 2018 Published 19 February 2018 Volume 9 - 2018 Edited by Tobias Schuerholz, Universittsmedizin Rostock, Germany Reviewed by Sergio Ivn Valds-Ferrer, Instituto Nacional de Ciencias Mdicas y Nutricin Salvador Zubirn, Mexico
435 Multiple clinical studies have already demonstrated its potential value, 436,437 indicating that SG-1002 warrants further investigation in the treatment of H 2 S-related diseases in the future
There are various kinds of drips only the constituent solutions vary
It upregulates genes involved in collagen synthesis (COL1A1, COL3A1, COL5A1), extracellular matrix remodeling (decorin, fibromodulin), and antioxidant defense (superoxide dismutase, glutathione peroxidase) while simultaneously suppressing genes associated with inflammation (IL-6, TNF-alpha), fibrinogen production, and tissue destruction (several MMPs)